Risk of sudden cardiac death in chronic kidney disease

Area of Science:

• Nephrology
• Cardiology
• Clinical Medicine

Background:

• Chronic kidney disease (CKD) significantly increases the risk of sudden cardiac death (SCD), independent of atherosclerotic cardiovascular disease.
• Renal impairment is a progressive risk factor for SCD, escalating with declining kidney function and peaking in end-stage renal disease patients requiring dialysis.

Purpose of the Study:

• To review the epidemiology and mechanisms of SCD in CKD patients.
• To highlight the need for improved noninvasive risk stratification strategies for SCD in CKD.
• To explore potential therapeutic targets and diagnostic tools for SCD risk in renal patients.

Main Methods:

• Review of existing literature on SCD in CKD.
• Analysis of shared risk factors and independent contributions of renal impairment to SCD.
• Examination of potential mechanisms including autonomic imbalance, uremic cardiomyopathy, and electrolyte disturbances.
• Evaluation of current risk stratification tools and proposed novel approaches.

Main Results:

• Renal impairment is an independent and escalating risk factor for SCD across all stages of CKD.
• Mechanisms like autonomic imbalance, uremic cardiomyopathy, and electrolyte disturbances contribute to increased arrhythmic risk.
• Current strategies for selecting patients for cardioverter defibrillator therapy are problematic in dialysis patients.
• Noninvasive electrophysiological testing during dialysis may offer a standardized method for risk stratification.

Conclusions:

• CKD patients face a high, intrinsic risk of SCD requiring targeted management strategies.
• Addressing autonomic imbalance, uremic cardiomyopathy, and electrolyte disturbances may mitigate SCD risk.
• Development of effective, noninvasive risk stratification tools, potentially including electrophysiological testing during dialysis, is essential for guiding treatment decisions and improving outcomes in CKD patients.